Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Personalis Market Cap 2018-2025 | PSNL

Personalis market cap history and chart from 2018 to 2025. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Personalis market cap as of May 21, 2025 is $0.44B.
  
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.438B $0.085B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.026B 6.88
Dr Reddy's Laboratories (RDY) India $12.104B 21.97
BridgeBio Pharma (BBIO) United States $6.401B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.859B 15.09
Bausch Health Cos (BHC) Canada $1.695B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.191B 7.93
Taysha Gene Therapies (TSHA) United States $0.629B 0.00
Assembly Biosciences (ASMB) United States $0.111B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00